Opportunity

CanadaBuys #PS27RFPFORLENALIDOMIDANDPOMALIDOMIDE

Solicitation for Oncology Lenalidomide and Pomalidomide Oral Solids for HealthPRO Canada

Posted

June 09, 2026

Respond By

July 14, 2026

Identifier

PS27RFPFORLENALIDOMIDANDPOMALIDOMIDE

NAICS

424210

HealthPRO Procurement Services Inc., a national healthcare group purchasing organization, is seeking proposals for the supply of oncology medications Lenalidomide and Pomalidomide in oral solid form. - Government Buyer: - HealthPRO Procurement Services Inc. (on behalf of Nova Scotia Health and IWK) - Products/Services Requested: - Lenalidomide Oral Solids (oncology medication) - Pomalidomide Oral Solids (oncology medication) - No specific part numbers or quantities provided - OEMs and Vendors: - No specific manufacturers or vendors named in the notice - Notable Requirements: - Contract duration is estimated at 36 months - Procurement is governed by the Canadian Free Trade Agreement (CFTA) and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) - Participation is subject to existing HealthPRO Canada contracts - Full details are available on a third-party site

Description

HealthPRO Procurement Services Inc. is soliciting proposals for a contract involving Oncology Lenalidomide and Pomalidomide Oral Solids. The contract duration is estimated to be 36 months. This procurement is conducted under the Canadian Free Trade Agreement (CFTA) and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). Participation is subject to existing contracts and full details are available on a third-party site.

View original listing